What is molecular hydrogen therapy and how does it work?+
Molecular hydrogen therapy involves administering H2 gas or hydrogen-dissolved water to achieve therapeutic concentrations of dissolved molecular hydrogen in body tissues. H2 is a selective antioxidant that specifically neutralizes hydroxyl radical (·OH) and peroxynitrite (ONOO⁻) — the two most damaging reactive oxygen species (ROS) — without neutralizing beneficial ROS like hydrogen peroxide or superoxide that the body uses for normal cellular signaling. Over 1,700 peer-reviewed studies have investigated H2's therapeutic effects across inflammation, metabolism, neurology, and recovery.
What conditions and goals can hydrogen therapy address?+
Clinical and preclinical research supports hydrogen therapy for: reducing systemic and localized inflammation; supporting athletic recovery and reducing DOMS (delayed onset muscle soreness); improving metabolic markers in metabolic syndrome and diabetes; neuroprotective effects in neurodegenerative conditions; reducing oxidative damage from medical treatments; post-surgical recovery; and general anti-aging and longevity support. BHRC primarily uses hydrogen therapy for recovery optimization, anti-inflammatory support, and as a component of longevity protocols.
How does hydrogen reduce oxidative stress?+
Oxidative stress occurs when reactive oxygen species (ROS) production exceeds the body's antioxidant capacity, damaging DNA, proteins, and lipid membranes. Hydroxyl radical (·OH) is the most damaging ROS — it is extremely reactive, cannot be enzymatically neutralized, and causes oxidative damage wherever it forms. Molecular hydrogen reacts directly with ·OH to form harmless water (H2O). Unlike vitamin C or E, H2 does not deplete enzymatic antioxidant systems and does not interfere with beneficial ROS signaling.
How many hydrogen therapy sessions are recommended?+
For acute goals (inflammation reduction, post-procedure recovery), BHRC typically recommends 8–12 sessions over 4–6 weeks. For ongoing wellness and longevity support, monthly maintenance of 2–4 sessions is common. Athletes using hydrogen therapy for training recovery often schedule sessions on heavy training days or the day after. Your BHRC provider will design a session frequency based on your specific goals and response.
Is hydrogen therapy safe?+
Yes. Molecular hydrogen has been extensively studied for safety and is classified as Generally Recognized As Safe (GRAS) for food applications. H2 inhalation at 2–4% concentrations (well below the flammability threshold of 4.7%) has been used in thousands of clinical patients across multiple countries without adverse effects. There are no known drug interactions, no contraindications for healthy adults, and no cumulative toxicity. The medical devices used at BHRC are calibrated to maintain therapeutic concentrations within safe parameters.
Can I combine hydrogen therapy with other BHRC treatments?+
Yes — and BHRC encourages it. Hydrogen therapy pairs naturally with NAD+ IV therapy (both address mitochondrial function), IV drip therapy (cellular nutrition + antioxidant protection), NovoTHOR photobiomodulation (complementary mitochondrial support), and post-procedure recovery protocols. Many BHRC patients add H2 sessions on the same day as IV infusions for a combined longevity session.
What does a hydrogen therapy session feel like?+
H2 inhalation sessions at BHRC are simple and relaxing. You sit or recline comfortably while breathing through a nasal cannula or light mask delivering 2–4% H2 in air. The gas is colorless and odorless — you will not notice anything unusual about what you're breathing. Many patients read, work on a laptop, or rest during the 30–60 minute session. Some patients report a noticeable calm or relaxed mental state during the session — a consistent subjective report in clinical literature.
Is there scientific evidence for hydrogen therapy?+
Yes — substantial and growing. Over 1,700 peer-reviewed publications have investigated molecular hydrogen's biological effects since the landmark 2007 Nature Medicine paper by Ohsawa et al. demonstrating selective hydroxyl radical scavenging. Human clinical trials have shown statistically significant results in metabolic syndrome, Parkinson's disease, rheumatoid arthritis, radiation-induced adverse effects, and athletic performance. BHRC providers can share relevant clinical literature during your consultation.
